initi
submit
januari
accept
public
june
one
import
assumpt
casecontrol
studi
control
select
independ
exposur
nevertheless
hypothes
viru
interfer
might
lead
correl
receipt
influenza
vaccin
increas
risk
infect
respiratori
virus
investig
whether
phenomenon
might
affect
studi
design
commonli
use
estim
influenza
vaccin
effect
search
public
medlin
pubm
web
scienc
identifi
studi
use
testneg
design
report
estim
separ
deriv
altern
control
group
patient
test
neg
influenza
flu
patient
test
posit
otheranoth
respiratori
viru
orv
orv
patient
test
neg
virus
panel
pan
includ
estim
countri
age
group
observ
differ
vaccin
coverag
orvposit
panneg
control
group
total
estim
orv
estim
estim
extract
pool
estim
differ
similar
group
metaregress
associ
found
select
control
group
estim
conclus
find
differ
estim
base
choic
control
group
epidemiolog
method
influenza
testneg
design
vaccin
effect
viru
interfer
abbrevi
ci
confid
interv
ed
emerg
depart
orv
otheranoth
respiratori
viru
pcr
polymeras
chain
reaction
rsv
respiratori
syncyti
viru
tnd
testneg
design
vaccin
effect
influenza
vaccin
effect
measur
avail
reduc
substanti
annual
diseas
burden
associ
influenzaviru
infect
influenza
vaccin
gener
moderatetogood
efficaci
estim
fall
within
rang
children
adult
base
random
control
trial
howev
influenza
vaccin
efficaci
vaccin
effect
vari
year
year
depend
degre
antigen
match
strain
select
inclus
vaccin
circul
strain
well
interv
vaccin
influenza
epidem
also
vari
among
subpopulationsperson
differ
age
exampl
factor
may
affect
experiment
observ
studi
design
thu
annual
estim
influenza
provid
ongo
evid
perform
influenza
vaccin
commun
although
random
control
trial
consid
gold
standard
measur
vaccin
efficaci
purpos
make
annual
estim
observ
studi
carri
commonli
feasibl
effici
ethic
testneg
design
tnd
wide
appli
measur
influenza
routin
basi
europ
north
america
australia
asia
sinc
studi
design
patient
sign
symptom
meet
predefin
clinic
definit
eg
acut
respiratori
infect
influenzalik
ill
swab
test
influenza
virus
case
test
may
done
panel
respiratori
virus
person
test
posit
defin
case
test
neg
influenza
virus
influenza
flu
neg
classifi
control
person
test
neg
may
test
posit
anoth
respiratori
viru
otheranoth
respiratori
viru
orv
posit
may
test
neg
virus
panel
panel
pan
neg
estim
adj
adj
odd
ratio
compar
odd
vaccin
among
case
odd
vaccin
among
control
adjust
potenti
confound
age
design
embed
within
exist
surveil
system
enabl
time
estim
inpati
outpati
set
reason
cost
although
number
studi
use
tnd
increas
theoret
underpin
inher
assumpt
tnd
need
evalu
type
casecontrol
studi
tnd
follow
basic
principl
control
select
control
select
popul
case
control
select
independ
exposur
within
stratum
factor
includ
stratifi
analysi
restrict
case
control
attend
outpati
clinic
hospit
clinic
case
definit
eg
influenzalik
ill
tnd
includ
control
sourc
popul
case
thu
reduc
bia
differenti
healthcareseek
behavior
howev
tnd
studi
conduct
inpati
set
could
complic
acut
exacerb
chronic
respiratori
condit
could
difficult
distinguish
respiratori
viru
infect
requir
hospit
furthermor
popul
like
receiv
influenza
vaccin
sourc
popul
select
bia
would
introduc
nevertheless
metaanalysi
compar
inpati
outpati
feng
et
al
observ
similar
estim
set
analysi
restrict
season
countri
age
group
simul
studi
examin
valid
tnd
inpati
set
foppa
et
al
conclud
estim
would
bias
chronic
respiratori
condit
wellcontrol
analysi
assumpt
vaccin
coverag
estim
might
differ
accord
differ
control
group
higher
vaccin
coverag
thu
higher
estim
would
observ
use
panneg
control
assumpt
casecontrol
studi
control
select
independ
exposur
influenza
studi
assumpt
may
violat
risk
infect
noninfluenza
viru
independ
vaccin
statu
random
control
trial
cowl
et
al
observ
increas
risk
orv
infect
among
trival
influenza
vaccin
recipi
sever
epidemiolog
studi
observ
viral
interfer
phenomenon
infect
one
viru
alter
suscept
infect
anoth
viru
report
exampl
influenzaviru
rhinoviru
influenzaviru
respiratori
syncyti
viru
rsv
purport
underli
mechan
behind
phenomena
might
involv
nonspecif
immun
influenzavirusspecif
immun
viral
infect
temporari
nonspecif
immun
second
infect
induc
could
last
sever
week
given
brief
durat
investig
might
unlik
observ
popul
cohort
effect
contrast
influenzavirusspecif
interfer
may
involv
tcellmedi
immun
may
last
month
broad
heterotyp
crossreact
immun
respons
might
vari
across
differ
influenza
strain
could
possibl
evid
influenza
pandem
wherein
specif
influenza
strain
predomin
season
although
nonspecif
specif
immun
influenza
infecti
diseas
broadli
describ
potenti
natur
biolog
mechan
viru
interfer
remain
unclear
tnd
viru
interfer
may
import
prevent
influenza
infect
vaccin
nonspecif
influenzavirusspecif
immun
induc
leav
vaccine
suscept
infect
cocircul
virus
might
otherwis
protect
would
result
higher
influenza
vaccin
coverag
among
control
orv
detect
control
viru
detect
therefor
select
control
could
lead
bias
estim
estim
deriv
use
orvposit
group
would
higher
panneg
group
fluneg
group
simul
studi
suggest
phenomenon
produc
bias
estim
bia
trivial
except
extrem
condit
howev
simul
often
simplist
represent
real
studi
may
abl
captur
nuanc
immunolog
phenomena
exampl
immunolog
respons
may
less
appar
elderli
children
young
adult
possibl
immunosenesc
thu
evalu
potenti
bia
caus
viru
interfer
consid
age
popul
review
aim
assess
whether
viru
interfer
could
affect
estim
gener
studi
use
tnd
first
compar
vaccin
coverag
use
altern
control
group
second
compar
estim
accord
choic
control
group
third
summar
total
differ
estim
assess
deviat
zero
final
assess
whether
differ
equal
appar
among
age
group
differ
studi
set
previous
review
tnd
studi
estim
influenza
current
review
reassess
paper
deriv
previou
search
last
perform
decemb
conduct
onlin
updat
april
follow
previou
search
strategi
paper
search
pubm
nation
librari
medicin
bethesda
maryland
medlin
nation
librari
medicin
web
scienc
clariv
analyt
philadelphia
pennsylvania
follow
combin
keyword
influenza
flu
vaccin
effect
testneg
test
neg
casecontrol
case
control
set
articl
independ
screen
author
sf
sg
studi
estim
influenza
season
influenza
typesubtyp
type
influenza
vaccin
consid
articl
publish
english
consid
studi
subanalys
studi
reanalyz
previous
publish
data
report
interim
estim
use
tnd
exclud
studi
meet
inclus
criteria
screen
includ
influenza
estim
use
altern
control
group
includ
fluneg
orvposit
panneg
control
studi
design
inform
extract
includ
studi
use
standard
form
includ
author
public
year
studi
countri
influenza
season
popul
age
studi
set
surveil
system
case
definit
time
interv
sinc
symptom
onset
type
swab
laboratori
method
orv
test
vaccin
coverag
control
group
covari
includ
statist
model
estim
use
altern
control
group
differ
influenza
vaccin
coverag
estim
influenza
b
accord
altern
control
group
compar
pair
test
adjust
estim
obtain
use
avail
control
group
extract
includ
fluneg
group
denot
orvposit
group
denot
orv
panneg
group
denot
stratifi
estim
also
extract
influenza
typesubtyp
age
group
influenza
season
set
inpati
outpati
studi
differ
avail
estim
defin
calcul
confid
interv
bootstrap
use
resampl
see
web
appendix
avail
http
academicoupcomaj
exclud
studi
larg
uncertainti
defin
confid
interv
rang
percentag
point
remain
studi
pool
estim
orv
orv
influenza
b
calcul
studi
provid
overal
estim
estim
subgroup
remov
overal
estim
avoid
overlap
perform
egger
test
orv
standard
error
assess
public
bia
fixedeffect
model
assum
heterogen
examin
mean
statist
cochran
q
test
invers
varianc
orv
use
weight
studi
test
hypothesi
viru
interfer
may
vari
age
estim
orv
age
groupthat
children
age
year
young
adult
age
year
older
adult
age
year
sinc
inpati
studi
may
bias
due
recruit
patient
chronic
respiratori
diseas
rather
viral
infect
also
examin
set
whenev
possibl
evalu
whether
pool
orv
differ
zero
among
children
young
adult
among
elderli
adult
examin
whether
studi
design
featur
associ
estim
also
conduct
metaregress
mean
univari
multivari
randomeffect
model
predictor
includ
age
group
children
adult
elderli
age
studi
set
inpatientoutpatientmix
season
singlemultipl
restrict
patient
present
health
care
within
day
yesno
exclus
use
polymeras
chain
reaction
pcr
revers
transcript
pcr
test
yesno
number
orv
test
type
control
group
fluneg
orvposit
panneg
analys
conduct
use
r
version
r
foundat
statist
comput
vienna
austria
metafor
packag
total
public
retriev
previou
studi
articl
obtain
new
search
base
testneg
studi
articl
met
inclus
criteria
identifi
figur
two
studi
report
estim
popul
kelli
first
studi
estim
use
altern
control
group
studi
australia
studi
characterist
summar
tabl
studi
cover
influenza
season
countri
includ
australia
studi
unit
state
studi
japan
studi
china
hong
kong
studi
portug
studi
new
zealand
studi
netherland
studi
tabl
five
studi
report
estim
singl
year
other
report
estim
across
multipl
year
among
studi
report
pool
estim
across
yearseason
studi
also
provid
seasonspecif
estim
patient
age
investig
studi
children
studi
children
adult
elderli
person
studi
eight
studi
carri
exclus
outpati
set
includ
ed
carri
inpati
set
use
inpati
outpati
estim
broken
set
recruit
outpati
includ
ed
patient
urgentcar
patient
acutecar
patient
variou
case
definit
identifi
studi
use
influenzalik
ill
definit
n
studi
other
acut
respiratori
infect
definit
n
one
use
either
influenzalik
ill
acut
respiratori
infect
definit
anoth
requir
hospit
pneumonia
n
japanes
studi
requir
use
rapid
influenza
detect
test
case
definit
use
summar
web
tabl
studi
includ
fever
histori
fever
clinic
case
definit
except
studi
enrol
hospit
pneumonia
patient
variou
restrict
appli
inclus
patient
base
interv
symptom
onset
clinic
present
includ
present
within
day
day
day
studi
specifi
restrict
tabl
studi
estim
use
fluneg
orvposit
control
seven
also
report
estim
obtain
use
panneg
control
studi
perform
pcrrevers
transcript
pcr
influenza
diagnosi
among
patient
subset
patient
studi
also
use
immunofluoresc
andor
viru
cultur
tabl
number
orv
includ
respiratori
panel
rang
includ
studi
test
rsv
commonli
includ
virus
human
metapneumoviru
n
studi
adenoviru
n
rhinoviru
n
tabl
studi
report
number
specimen
test
posit
orv
test
studi
commonli
detect
orv
rsv
rhinoviru
account
total
orv
detect
respect
weak
neg
correl
number
orv
includ
panel
proport
patient
identifi
panneg
r
statist
signific
p
proport
control
identifi
panneg
lowest
among
children
us
studi
australian
studi
conduct
ed
anoth
australian
studi
conduct
outpati
set
tabl
proport
patient
test
posit
orv
fluneg
group
rang
among
peopl
age
year
japan
among
children
age
month
unit
state
interquartil
rang
studi
tabl
vaccin
coverag
report
studi
variou
control
group
consid
addit
vaccin
coverag
age
group
control
group
calcul
studi
suffici
detail
provid
piers
et
al
report
result
studi
set
inpati
outpati
feng
et
al
levi
et
al
report
result
season
sundaram
et
al
report
result
age
group
abl
calcul
estim
total
triplet
studi
tabl
vaccin
coverag
estim
fluneg
group
rang
among
inpati
children
age
year
hong
kong
china
among
outpati
children
age
year
australia
differ
vaccin
coverag
orvposit
panneg
group
rang
tabl
howev
pair
test
compar
mean
vaccin
coverag
group
suggest
statist
differ
p
differ
vaccin
coverag
point
estim
higher
identifi
ageor
settingspecif
pattern
larger
smaller
univari
analysi
extract
estim
orv
estim
estim
comparison
distribut
orv
estim
shown
figur
distribut
estim
shown
figur
observ
estim
correl
mostli
distribut
close
ident
line
among
estim
estim
person
age
children
specif
older
adult
estim
influenza
b
virus
other
calcul
specif
influenza
type
subtyp
web
figur
studi
estim
adjust
potenti
confound
includ
age
adjust
calendar
time
proxi
chang
influenza
activ
calcul
orv
orv
avail
estim
find
evid
public
bia
assess
orv
standard
error
p
statist
signific
differ
observ
estim
except
report
van
doorn
et
al
restrict
estim
analyz
confid
interv
span
percentag
point
less
estim
orv
estim
estim
remain
analysi
web
figur
point
estim
orv
rang
forti
estim
absolut
valu
less
web
figur
estim
exclud
metaanalysi
shown
web
figur
metaanalysi
remov
pool
estim
estim
age
stratuminfluenza
season
avail
n
estim
pool
orv
influenza
b
virus
cochran
q
test
impli
concern
heterogen
includ
e
subject
orvposit
control
group
subject
panneg
control
group
miss
data
vaccin
statu
person
miss
vaccin
statu
exclud
vaccin
statu
categor
unknown
includ
analysi
q
df
p
pool
orv
confid
interv
ci
estim
pair
differ
estim
orv
consist
substanti
differ
estim
fluneg
orvposit
group
similarli
pool
estim
ci
n
orv
ci
n
web
figur
show
confid
interv
estim
span
percentag
point
conduct
metaanalysi
orv
estim
children
estim
adult
estim
elderli
estim
pool
orv
ci
children
ci
young
adult
ci
older
adult
abl
identifi
trend
among
age
group
also
perform
sensit
analysi
restrict
estim
specif
influenza
typessubtyp
b
set
inpati
outpati
pool
estim
ci
orv
estim
inpati
set
ci
orv
estim
outpati
set
observ
pool
orv
statist
differ
zero
perform
metaregress
explor
factor
may
contribut
use
univari
multivari
randomeffect
model
univari
model
estim
higher
estim
children
p
person
age
p
inpati
p
web
tabl
associ
observ
estim
choic
control
group
similarli
observ
interact
age
group
select
control
group
p
result
shown
multivari
regress
also
observ
signific
associ
choic
control
group
p
orv
p
web
tabl
base
studi
identifi
tnd
public
provid
estim
orv
estim
estim
find
statist
differ
type
control
group
pair
test
assess
vaccin
coverag
also
demonstr
differ
choic
control
group
although
observ
orv
less
zero
report
studi
differ
consist
observ
season
pool
orv
estim
pair
observ
ci
suggest
choic
control
group
unlik
significantli
affect
estim
use
tnd
nonspecif
immun
respons
influenzaviru
involv
activ
natur
killer
cell
macrophag
dendrit
cell
immun
function
known
decreas
age
therefor
assum
phenomenon
viru
interfer
may
preval
among
younger
rather
older
age
group
howev
analysi
strongli
support
hypothesi
although
age
group
correl
estim
observ
interact
age
group
choic
control
group
multivari
metaregress
acknowledg
sampl
size
small
number
studi
examin
phenomenon
increas
evid
viru
interfer
may
aris
viru
interfer
may
act
differ
typesubtyp
exampl
interfer
rsv
influenza
may
pronounc
interfer
rsv
influenza
b
dr
karen
lauri
collabor
center
refer
research
influenza
peter
doherti
institut
infect
immun
melbourn
victoria
australia
person
commun
howev
identifi
statist
signific
estim
among
typessubtyp
analysi
effect
limit
sampl
size
select
bia
may
aris
inpati
studi
patient
hospit
due
chronic
underli
condit
infect
also
like
vaccin
studi
identifi
studi
report
inpati
result
observ
trend
pool
estim
set
differ
zero
found
proport
panneg
control
vari
substanti
among
studi
differ
could
partial
explain
number
orv
test
howev
observ
nonsignific
weak
neg
correl
number
orv
test
proport
panneg
type
virus
includ
panel
may
also
affect
proport
panneg
exampl
studi
report
detect
rate
orv
rhinoviru
rsv
commonli
detect
studi
hong
kong
includ
rhinoviru
could
explain
studi
highest
proport
panneg
differ
proport
panneg
like
also
associ
viral
load
shed
except
hong
kong
studi
studi
involv
children
present
low
proport
panneg
subject
among
elig
subject
consist
observ
higher
viral
load
shed
children
heterogen
viral
shed
age
suggest
potenti
misclassif
bia
panneg
group
result
may
like
falseneg
among
sampl
taken
older
patient
reason
falseneg
influenza
result
may
associ
suboptim
swab
qualiti
imperfect
laboratori
test
method
long
interv
symptom
onset
present
factor
could
contribut
misclassif
infect
statu
contribut
larger
orv
valu
circumst
orvposit
group
could
consid
one
provid
accur
estim
demonstr
swab
swab
method
suffici
qualiti
detect
viru
conclus
base
studi
estim
use
altern
control
group
find
evid
viru
interfer
suggest
estim
obtain
mean
tnd
bias
viru
interfer
use
fluneg
control
like
produc
estim
reliabl
orvposit
panneg
control
resourcesav
perspect
investig
surveil
system
research
scheme
use
tnd
measur
influenza
may
consid
test
orv
estim
influenza
simul
studi
incorpor
multipl
sourc
bia
examin
phenomenon
differ
age
group
could
help
confirm
refut
find
